Press releases, news stories and media library. We at Intelligent Implants are developing breakthrough bioelectronics. Here are some of the most current and up-to-date highlights.
Intelligent Implants, a developer and manufacturer of the unique SmartFuse system, is pleased to announce that the U.S. Patent and Trademark Office has granted the company a patent for the company’s SmartFuse technology. The patent, titled "System and method for dynamically stimulating bone growth" (US 10/292,831) relates to a system for using an electrical stimulation system in an orthopedic implant, using electrical stimulation is an extremely efficient way of stimulating bone growth, the system also monitors bone growth in real-time and has the capability to steer the bone to grow where we want it within fusion space. “We are excited to have this patent. It represents what we have stated from the start of the company; SmartFuse is the future for orthopedic implants”, said John Zellmer, CEO of Intelligent Implants.
Sixteen startups competed in the 2019 Texas A&M New Ventures Competition for more than $350,000 in cash and in-kind services — the largest pool of prizes in the contest's history. Several Houston startups competed in the technology- and science-focused pitch competition, and the top three prizes were claimed by Houstonians. Of the semifinalists, seven were related to the TMC Innovation Institute. Intelligent Implants claimed a $25k cash prize as a third place winner.
ABC 13 features some of the work being done by Intelligent Implants at Texas Medical Center's Innovation Institute to create a never-before-tried concept. The news segment showcases the cutting-edge invention, the SmartFuse, and explains how it candrastically improve success rates for spinal fusion procedures. The news segment also presents expert opinions on why the technology is significant in the field.
Intelligent Implants is featured on InnovationMap following its successful presentation for demo day at Houston's award-winning medical devices accelerator program , TMCx. The program provides startup companies with shared workspace, a curriculum tailored to the needs of health care entrepreneurs and the guidance of over 200 advisors from the front lines of the industry. Participants develop their companies by attending a variety of workshops and hands-on events to gain insights from experts in every facet of running a health-related business: clinical trials, FDA regulations, HIPAA/HITECH compliance, hospital procurement, commercial pilots, intellectual property, licensing, fundraising, marketing and other critical areas.
Intelligent Implants is selected as Most Promising Life Science Company at the 2018 Texas Life Science Forum hosted by the Rice Alliance and BioHouston. Ten early-stage companies were chosen by investors as the “Rice Alliance Most Promising Life Science Companies” from among those having raised less than $2 million in funding to-date. The Texas Life Science Forum is the premier life science event in Texas that brings together members from industry, emerging life science companies, academic, and investors.
Intelligent Implants is featured on the front page of the business section of the Houston Chronicle. Enterprise reporter Andrea Leinfelder follows the trajectory and success of Intelligent Implants in Houston through its different institutions. The article highlights the nature of the ecosystem that is being built at the Texas Medical Center and how Intelligent Implants has participated in it to grow the company and develop its product.
Intelligent Implants was awarded $250,000 from the $25 million Texas Medical Center (TMC) Venture Fund, supporting early-stage health care companies. The TMC Venture Fund accomplishes one of the key tenets of the Texas Medical Center’s strategic plan by transforming innovative ideas into tangible solutions for improving health. The fund provides monetary resources to young startups in the health care space with a nexus to Houston and the Texas Medical Center. These early, but critical-stage investments heighten companies’ chances of receiving additional funding and long-term success.
As part of the collaboration with Johnson & Johnson Innovation, the angelMD Catalyst Fund will make a $50,000 investment each in Intelligent Implants. In addition, angelMD will feature Intelligent Implants on its investment platform for angelMD members to invest an additional $350,000 in the company. The investments were officially announced by Charlie Emley, Catalyst Fund Managing Partner, at the 2017 MedTech Conference in San Jose, California.
Intelligent Implants is proud to announce that they are one of the winners in J&J´s global device start-up competition. In conjunction with the Grand Opening of the Center for Device Innovation (CDI @ TMC) in the Fall 2017, Johnson & Johnson Innovation and Johnson & Johnson Medical Devices launched the CDI @ TMC QuickFire Challenge, a device-focused challenge aimed at game-changing early-stage medical device innovations across strategic
CALIN, is a new €12 million life science network to assist Irish and Welsh businesses to innovate by offering open access to a unique strategic international partnership involving 6 world leading higher educational institutions and global healthcare leaders Unilever and GE Healthcare.
With the aid of Johnson and Johnson Innovation, Intelligent Implants has opened its Houston,TX office. The Johnson & Johnson Innovation family of companies (including JLABS) helps companies efficiently access expertise, funding, services and facilities to advance business and science.
Out of 50+ submissions, only 11 most promising start-ups were chosen to showcase their innovations to the Conference attendees, potential business partners and investors.
Enterprise Ireland is the state agency responsible for supporting the development of manufacturing and internationally traded services companies. They provide funding and support for companies - from entrepreneurs with business propositions for a high potential start-up through to large companies expanding their activities. Intelligent Implants has graciously accepted funding support from EI in a collaborative effort to advance our technologies and bring research and industry to Ireland.
In version 7 of the HAX demo day, the accelerator debuted thirteen new startups from its Shenzhen-based Accelerator program, alongside ten companies from the HAX Boost program, a second stage program from SOSV Revolution offices in SF. Intelligent Implants introduced its technology to a crowd of investors, press and local and foreign entrepreneurs.